Published Apr 30, 2026, 7:27 PM ET · Updated 6 months ago · 1 source
Seaport Therapeutics Said to Raise $255 Million in IPO
bloomberg
·
Original Report
INFERY
Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, raised nearly $255 million in an upsized US initial public offering that priced at the top of its marketed range, according to people familiar with the matter.